Computer-aided design, synthesis and evaluation of new SARS-CoV-2 Mpro inhibitors based on 1,5,6,7-tetrahydro-4H-indazol-4-one scaffold

被引:0
|
作者
Piven, Yuri A. [1 ]
Zinovich, Veronica G. [1 ]
Shcherbakov, Dmitriy N. [2 ,3 ]
Chirkova, Varvara Yu. [2 ]
Belenkaya, Svetlana V. [3 ]
Puzanau, Raman M. [4 ]
Khlebnicova, Tatyana S. [1 ]
Lakhvich, Fedor A. [1 ]
机构
[1] Natl Acad Sci Belarus, Inst Bioorgan Chem, Acad Kuprevicha St 5-2, Minsk 220141, BELARUS
[2] Altay State Univ, Leninski Pr 61, Barnaul 656049, Russia
[3] State Res Ctr Virol & Biotechnol Vector, Koltsov, Russia
[4] Hlth Care Inst Natl Antidoping Lab, Borovlyansky S-s,106-1, Lesnoy 223040, BELARUS
关键词
1; 5; 6; 7-Tetrahydro-4H-indazol-4-ones; SARS-CoV-2; M-pro; 3CL(pro); Molecular docking; Molecular dynamics; MAIN PROTEASE INHIBITORS; SARS; DRUGS;
D O I
10.1007/s00044-023-03174-z
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel class of SARS-CoV-2 main protease (M-pro) inhibitors derived from 1,5,6,7-tetrahydro-4H-indazol-4-ones was designed. Virtual screening based on molecular docking followed by molecular dynamics simulation and MM/GBSA calculations was used for selecting compounds for synthesis and an evaluation. After testing 29 prepared compounds for activity against M-pro, two hits with IC50 values bellow 60 mu M were found with the best result of 27.31 mu M for racemic amide 9m. SAR and further possibilities for hit optimization were discussed. The effectiveness of different approaches (MM/GBSA and alchemical ABFE) for protein-ligand binding affinity prediction was assessed on the basis of obtained experimental data. The best convergence was achieved when we carried out long molecular dynamics simulations (200 ns) of complexes from docking followed by calculations of free binding energies with MM/GBSA method and explicit accounting of entropy. [GRAPHICS]
引用
收藏
页码:151 / 163
页数:13
相关论文
共 50 条
  • [1] Computer-aided design, synthesis and evaluation of new SARS-CoV-2 Mpro inhibitors based on 1,5,6,7-tetrahydro-4H-indazol-4-one scaffold
    Yuri A. Piven
    Veronica G. Zinovich
    Dmitriy N. Shcherbakov
    Varvara Yu. Chirkova
    Svetlana V. Belenkaya
    Raman M. Puzanau
    Tatyana S. Khlebnicova
    Fedor A. Lakhvich
    Medicinal Chemistry Research, 2024, 33 : 151 - 163
  • [2] Molecular manipulation of the 1,5,6,7-tetrahydro-4H-indazol-4-one scaffold to obtain new human neutrophil elastase (HNE) inhibitors
    Cantini, Niccolo
    Crocetti, Letizia
    Guerrini, Gabriella
    Vergelli, Claudia
    Lamanna, Silvia
    Schepetkin, Igor A.
    Pallecchi, Marco
    Bartolucci, Gianluca
    Khlebnikov, Andrei, I
    Quinn, Mark T.
    Rossi, Patrizia
    Paoli, Paola
    Giovannoni, Maria Paola
    JOURNAL OF MOLECULAR STRUCTURE, 2022, 1263
  • [3] 1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors
    Cantini, Niccolo
    Crocetti, Letizia
    Guerrini, Gabriella
    Vergelli, Claudia
    Schepetkin, Igor A.
    Pallecchi, Marco
    Bartolucci, Gianluca
    Quinn, Mark T.
    Teodori, Elisabetta
    Giovannoni, Maria Paola
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 52
  • [4] Synthesis and Cytotoxic Activity of Tetrazole-Containing 1,5,6,7-Tetrahydro-4H-indazol-4-ones
    Khlebnicova, T. S.
    Zinovich, V. G.
    Piven, Yu A.
    Baranovsky, A., V
    Lakhvich, F. A.
    Trifonov, R. E.
    Golubeva, Yu A.
    Lider, E., V
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2022, 92 (03) : 359 - 366
  • [5] Synthesis and Cytotoxic Activity of Tetrazole-Containing 1,5,6,7-Tetrahydro-4H-indazol-4-ones
    T. S. Khlebniсova
    V. G. Zinovich
    Yu. A. Piven
    A. V. Baranovsky
    F. A. Lakhvich
    R. E. Trifonov
    Yu. A. Golubeva
    E. V. Lider
    Russian Journal of General Chemistry, 2022, 92 : 359 - 366
  • [6] Multicomponent synthesis of 1,5,6,7-tetrahydro-4H-indol-4-one derivatives
    Marchenko, Kateryna I.
    Kolos, Nadiia N.
    CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2023, 59 (11-12) : 717 - 722
  • [7] Multicomponent synthesis of 1,5,6,7-tetrahydro-4H-indol-4-one derivatives
    Kateryna I. Marchenko
    Nadiia N. Kolos
    Chemistry of Heterocyclic Compounds, 2023, 59 : 717 - 722
  • [8] 1-(2,4-Dibromophenyl)-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one A Novel Opioid Receptor Agonist with Less Accompanying Gastrointestinal Dysfunction than Morphine
    Chao, Po-Kuan
    Ueng, Shau-Hua
    Ou, Li-Chin
    Yeh, Teng-Kuang
    Chang, Wan-Ting
    Chang, Hsiao-Fu
    Chen, Shu-Chun
    Tao, Pao-Luh
    Law, Ping-Yee
    Loh, Horace H.
    Cheng, Ming-Fu
    Chuang, Jian-Ying
    Chen, Chiung-Tong
    Shih, Chuan
    Yeh, Shiu-Hwa
    ANESTHESIOLOGY, 2017, 126 (05) : 952 - 966
  • [9] ENHYDRAZINES .38. DISCRIMINATION BETWEEN 1,5,6,7-TETRAHYDRO-4H-INDAZOL-4-ONES AND 2,5,6,7-TETRAHYDRO-4H-INDAZOL-4-ONES IN THE C-13 NMR-SPECTRUM
    SUTTHIVAIYAKIT, S
    SUCROW, W
    WONNEMANN, H
    KRUGER, C
    LIEBIGS ANNALEN DER CHEMIE, 1985, (04): : 794 - 801
  • [10] Computer-aided drug design for virtual-screening and active-predicting of main protease (Mpro) inhibitors against SARS-CoV-2
    Dai, Renhui
    Gao, Hongwei
    Su, Ruiling
    FRONTIERS IN PHARMACOLOGY, 2023, 14